Julie D Klapstein Amedisys Inc (AMED) insider trading activity

Julie D Klapstein is Director of AMEDISYS INC. Currently has a direct ownership of 0 shares of AMED, which is worth approximately $0. The most recent transaction as insider was on Aug 14, 2025, when has been sold 16,031 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Julie D Klapstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2025	SELL Sale (or disposition) back to the issuer	-	16,031 Reduced 100.0%	0 Common Stock
May 03 2025	BUY Grant, award, or other acquisition	-	1,690 Added 9.54%	16,031 Common Stock
May 03 2024	BUY Grant, award, or other acquisition	-	1,678 Added 10.48%	14,341 Common Stock
May 03 2023	BUY Grant, award, or other acquisition	-	1,941 Added 13.29%	12,663 Common Stock
Jun 09 2022	BUY Grant, award, or other acquisition	-	1,304 Added 10.84%	10,722 Common Stock
Jun 08 2021	BUY Grant, award, or other acquisition	-	574 Added 5.74%	9,418 Common Stock

Also insider at

OSH

Oak Street Health, Inc. Healthcare

Director

MPLN

MultiPlan Corp Healthcare

Director

NXGN

NEXTGEN HEALTHCARE, INC. Healthcare

OMDA

Omada Health, Inc.

JDK